GlassScriptPhysician profile
Joseph C Eldridge
NPI 1588202493
$1,349.95
in general payments reported to CMS, 2019-2025
14 companies · $584 in 2025
The $584 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $162 · 2024: $604 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $252.46 | 2022-2025 | Epclusa |
| Corium, LLC | $125.00 | 2024 | Azstarys |
| Indivior INC. | $124.48 | 2025 | Sublocade |
| Abbvie INC. | $124.28 | 2025 | |
| Axsome Therapeutics, INC. | $122.04 | 2024 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $121.81 | 2024 | Uzedy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $120.63 | 2025 | Caplyta |
| Amgen INC. | $120.06 | 2024 | Krystexxa |
| Janssen Pharmaceuticals, INC | $115.16 | 2024 | Spravato |
| Exact Sciences Corporation | $36.17 | 2025 | Cologuard Collection Kit |
| Lundbeck LLC | $27.49 | 2025 | Rexulti |
| Ani Pharmaceuticals, INC. | $20.53 | 2025 | Purified Cortrophin Gel |
| Cranial Technologies, INC | $20.11 | 2022 | |
| Glaxosmithkline, LLC. | $19.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Eldridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.